Chemo-immunotherapy in patients with metastatic melanoma using sequential treatment with dacarbazine and recombinant human interleukin-2: evaluation of hematologic and immunologic parameters and correlation with clinical response.

Source:http://linkedlifedata.com/resource/pubmed/id/1446917

Download in:

View as

General Info

PMID
1446917